Buchmann Institut für Molekulare Lebenswissenschaften (BMLS)
Refine
Year of publication
Document Type
- Article (58)
- Preprint (28)
- Book (1)
- Contribution to a Periodical (1)
Has Fulltext
- yes (88)
Is part of the Bibliography
- no (88)
Keywords
- Cryoelectron microscopy (3)
- PROTAC (3)
- X-ray crystallography (3)
- Antimicrobial resistance (2)
- Biochemistry (2)
- C. elegans (2)
- Cell biology (2)
- additive manufacturing (2)
- machine learning (2)
- 3D image analysis (1)
- Alternative splicing (1)
- Autophagy (1)
- Bacterial biofilm (1)
- Biological Activity (1)
- Biotechnology (1)
- Blinatumomab (1)
- CD19 (1)
- CPVT (1)
- CRBN (1)
- CRISPR/Cas9 (1)
- CaMPARI (1)
- Calstabin2/FKBP12.6 (1)
- Cas9 inhibitor (1)
- Collective cell migration (1)
- Continuous Process Verification (1)
- Conventional and unconventional ubiquitination (1)
- Cp (1)
- Cpk (1)
- Cryoelectron tomography (1)
- DNA damage response (1)
- Degrader design (1)
- Drug Discovery (1)
- Drug delivery systems (1)
- E3 Ligase (1)
- E3-Ligases (1)
- Embryogenesis (1)
- Entomology (1)
- Enzyme mechanisms (1)
- Exitrons (1)
- Fluorescence imaging (1)
- Fluorescent Probes (1)
- GRAND-SLAM (1)
- Gene expression analysis (1)
- Genetic engineering (1)
- Genetic vectors (1)
- Genotyping and haplotyping (1)
- Homeoviscous adaptation (1)
- IAP (1)
- Immunotherapy (1)
- In vitro wound models (1)
- Ion channels in the nervous system (1)
- Julia (1)
- Kif15 mRNA (1)
- LAMTOR1 (1)
- LC3/GABARAP (1)
- LIMK1 (1)
- LIMK2 (1)
- LIR (1)
- Legionella pneumophila (1)
- Light-sheet fluorescence microscopy (1)
- Light-sheet microscopy (1)
- Lipid packing (1)
- Long-read sequencing (1)
- Medicinal chemistry (1)
- Membrane fluidity (1)
- Membrane homeostasis (1)
- Microbiology (1)
- Molecular glue (1)
- Molecular neuroscience (1)
- Morphogenesis (1)
- Multiphoton microscopy (1)
- NanoBRET (1)
- New E3-ligase ligands (1)
- Optogenetics (1)
- Oxford Nanopore Technologies (1)
- P23/PTGES3 (1)
- Particle image velocimetry (1)
- Pathogens (1)
- Performance Metrics (1)
- Permeation and transport (1)
- Pharmaceutical (1)
- Pharmacology (1)
- Pp (1)
- Ppk (1)
- Process Capability (1)
- Process Performance (1)
- Process Validation (1)
- Profiling Transthiolation Activity (1)
- Protein folding (1)
- Proteins (1)
- Purkinje cell (1)
- RNA stability (1)
- RNA-binding protein (1)
- Rab7 (1)
- Ragulator complex (1)
- Regulation of lipid metabolism (1)
- Reverse transcription (1)
- RyR2 (1)
- S107 (1)
- SARS-CoV-2 (1)
- SLAM-seq (1)
- SPC (1)
- Small molecules (1)
- State of Control (1)
- Statisitcal Control (1)
- Statisitcal Process Control Chart (1)
- Stem-cell research (1)
- Structural biology (1)
- Target validation (1)
- Tie2 (1)
- Transcription factors (1)
- Transgenic organisms (1)
- Trend Analysis (1)
- Tribolium castaneum (1)
- Tumour-suppressor proteins (1)
- UBA5 (1)
- UFIM (1)
- UFM1 (1)
- USP32 (1)
- Ubiquitin (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ubiquitylation (1)
- VHL (1)
- Wound dressings (1)
- Wound infection (1)
- actin cytoskeleton dynamics (1)
- acyclovir (1)
- aging (1)
- angiogenesis (1)
- angipoietin (1)
- antiviral signaling (1)
- arrhythmia model (1)
- articular chondrocytes (1)
- assessment of reference bias (1)
- autophagy (1)
- basement membrane (1)
- big data (1)
- bioequivalence (1)
- blood vessels (1)
- blood–brain barrier (1)
- cGMP (1)
- calsequestrin (1)
- cancer (1)
- catalytic mechanism (1)
- cell cycle (1)
- ceramide phosphoinositols (1)
- cerebellum (1)
- chemical-induced proximity (1)
- chemogenomics (1)
- cofilin (1)
- confocal Raman microscopy (1)
- crosslinking (1)
- cytosolic free calcium (1)
- data curation (1)
- de novo design (1)
- de novo transcription (1)
- dendritic branching (1)
- dendritic morphology (1)
- deubiquitinase (DUB) (1)
- electrospinning (1)
- electrospray ionization-mass spectrometry (1)
- ether lipids (1)
- extracellular matrix (1)
- famotidine (1)
- gelatin (1)
- genome editing (1)
- gravity (1)
- guanylyl cyclase (GCY) (1)
- high content imaging (1)
- high throughput screening (1)
- histamine (1)
- human induced pluripotent stem cells (1)
- hypoxia (1)
- in vitro model (1)
- inflammation (1)
- isothermal titration calorimetry (ITC) (1)
- kinase (1)
- light-induced polymerization (1)
- lipid profiles (1)
- lipidomics (1)
- liver cancer (1)
- mRNA isoforms (1)
- mTORC1 (1)
- macrophage inflammatory response (1)
- medicinal chemistry (1)
- metabolic syndromes (1)
- migration (1)
- modularity of megasynthases (1)
- monocytes (1)
- multidomain protein (1)
- myxobacteria (1)
- neuro-vascular (1)
- neurodegeneration (1)
- neurodevelopment (1)
- non-invasive imaging (1)
- novel technologies (1)
- nuclear magnetic resonance (NMR) (1)
- open-source 3D bioprinting (1)
- optogenetics (1)
- organoids (1)
- parabolic flight (1)
- phagocytosis (1)
- phenotypic screening (1)
- phosphodiesterase (PDE) (1)
- phosphorylation (1)
- polycaprolactone (1)
- polyketide synthase (1)
- post-transcriptional control of gene expression (1)
- protein engineering (1)
- protein motif (1)
- reference bias (1)
- reversed phase (1)
- self-initiated photografting and photopolymerization (1)
- signal transduction (1)
- skin delivery (1)
- small-molecule inhibitor (1)
- stereolithography (1)
- sub-tomogram averaging (1)
- surface modification (1)
- surface-initiated polymerization (1)
- template bias (1)
- template matching (1)
- thermosensation (1)
- thermotaxis (1)
- tissue engineering (1)
- toll-like receptor (1)
- tumor microenvironment (1)
- tumor model (1)
- ubiquitin (1)
- ultra-performance liquid chromatography (1)
- v-ATPase (1)
- x-ray crystallography (1)
- π-clamp (1)
Institute
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (88)
- Biochemie, Chemie und Pharmazie (30)
- Medizin (23)
- Biowissenschaften (17)
- MPI für Biophysik (12)
- Physik (9)
- Biochemie und Chemie (7)
- Exzellenzcluster Makromolekulare Komplexe (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Frankfurt Institute for Advanced Studies (FIAS) (2)
Targeted protein degradation (TPD) has recently emerged as an exciting new drug modality. However, the strategy of developing small molecule-based protein degraders has evolved over the past two decades and has now established molecular tags that are already in clinical use, as well as chimeric molecules, PROteolysis TArgeting Chimeras (PROTACs), based mainly on ligand systems developed for the two E3 ligases CRBN and VHL. The large size of the human E3 ligase family suggests that PROTACs can be developed by targeting a large diversity of E3 ligases, some of which have restricted expression patterns with the potential to design disease- or tissue-specific degraders. Indeed, many new E3 ligands have been published recently, confirming the druggability of E3 ligases. This review summarises recent data on E3 ligases and highlights the challenges in developing these molecules into efficient PROTACs rivalling the established degrader systems.
MicroRNAs (miRNAs) are critical post-transcriptional regulators in many biological processes. They act by guiding RNA-induced silencing complexes to miRNA response elements (MREs) in target mRNAs, inducing translational inhibition and/or mRNA degradation. Functional MREs are expected to predominantly occur in the 3’ untranslated region and involve perfect base-pairing of the miRNA seed. Here, we generate a high-resolution map of miR-181a/b-1 (miR-181) MREs to define the targeting rules of miR-181 in developing murine T-cells. By combining a multi-omics approach with computational high-resolution analyses, we uncover novel miR-181 targets and demonstrate that miR-181 acts predominantly through RNA destabilization. Importantly, we discover an alternative seed match and identify a distinct set of targets with repeat elements in the coding sequence which are targeted by miR-181 and mediate translational inhibition. In conclusion, deep profiling of MREs in primary cells is critical to expand physiologically relevant targetomes and establish context-dependent miRNA targeting rules.
Key Points:
* Deep profiling identifies novel targets of miR-181 associated with global gene regulation.
* miR-181 MREs in repeat elements in the coding sequence act through translational inhibition.
* High-resolution analysis reveals an alternative seed match in functional MREs.
Cryo-electron tomography combined with subtomogram averaging (StA) has yielded high-resolution structures of macromolecules in their native context. However, high-resolution StA is not commonplace due to beam-induced sample drift, images with poor signal-to-noise ratios (SNR), challenges in CTF correction, and limited particle number. Here we address these issues by collecting tilt series with a higher electron dose at the zero-degree tilt. Particles of interest are then located within reconstructed tomograms, processed by conventional StA, and then re-extracted from the high-dose images in 2D. Single particle analysis tools are then applied to refine the 2D particle alignment and generate a reconstruction. Use of our hybrid StA (hStA) workflow improved the resolution for tobacco mosaic virus from 7.2 to 4.4 Å and for the ion channel RyR1 in crowded native membranes from 12.9 to 9.1 Å. These resolution gains make hStA a promising approach for other StA projects aimed at achieving subnanometer resolution.
Cryo electron tomography (cryo-ET) combined with subtomogram averaging (StA) enables structural determination of macromolecules in their native context. A few structures were reported by StA at resolution higher than 4.5 Å, however all of these are from viral structural proteins or vesicle coats. Reaching high resolution for a broader range of samples is uncommon due to beam-induced sample drift, poor signal-to-noise ratio (SNR) of images, challenges in CTF correction, limited number of particles. Here we propose a strategy to address these issues, which consists of a tomographic data collection scheme and a processing workflow. Tilt series are collected with higher electron dose at zero-degree tilt in order to increase SNR. Next, after performing StA conventionally, we extract 2D projections of the particles of interest from the higher SNR images and use the single particle analysis tools to refine the particle alignment and generate a reconstruction. We benchmarked our proposed hybrid StA (hStA) workflow and improved the resolution for tobacco mosaic virus from 7.2 to 5.2 Å and the resolution for the ion channel RyR1 in crowded native membranes from 12.9 to 9.1 Å. We demonstrate that hStA can improve the resolution obtained by conventional StA and promises to be a useful tool for StA projects aiming at subnanometer resolution or higher.
The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
(2019)
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS) is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.
RNA-binding proteins (RBPs) control every RNA metabolic process by multiple protein-RNA and protein-protein interactions. Their roles have largely been analyzed by crude mutations, which abrogate multiple functions at once and likely impact the structural integrity of the large ribonucleoprotein particles (RNPs) these proteins function in. Using UV-induced RNA-protein crosslinking of entire cells, protein complex purification and mass spectrometric analysis, we identified >100 in vivo RNA crosslinks in 16 nuclear mRNP components in Saccharomyces cerevisiae. For functional analysis, we chose Npl3, which displayed crosslinks in its two RNA recognition motifs (RRMs) and in the connecting flexible linker region. Both RRM domains and the linker uniquely contribute to RNA recognition as revealed by NMR and structural analyses. Interestingly, mutations in these regions cause different phenotypes, indicating distinct functions of the different RNA-binding domains. Notably, an npl3-Linker mutation strongly impairs recruitment of several mRNP components to chromatin and incorporation of other mRNP components into nuclear mRNPs, establishing a so far unknown function of Npl3 in nuclear mRNP assembly. Taken together, our integrative analysis uncovers a specific function of the RNA-binding activity of the nuclear mRNP component Npl3. This approach can be readily applied to RBPs in any RNA metabolic process.
RNA-binding proteins (RBPs) control every RNA metabolic process by multiple protein-RNA and protein-protein interactions. Their roles have largely been analyzed by crude mutations, which abrogate multiple functions at once and likely impact the structural integrity of the large messenger ribonucleoprotein particle (mRNP) assemblies, these proteins often function in. Using UV-induced RNA-protein crosslinking and subsequent mass spectrometric analysis, we first identified more than 100 in vivo RNA crosslinks in 16 nuclear mRNP components in S. cerevisiae. For functional analysis, we chose Npl3, for which we determined crosslinks in its two RNA recognition motifs (RRM) and in the flexible linker region connecting the two. Using NMR and structural analyses, we show that both RRM domains and the linker uniquely contribute to RNA recognition. Interestingly, mutations in these regions cause different phenotypes, indicating distinct functions of the different RNA-binding domains of Npl3. Notably, the npl3-Linker mutation strongly impairs recruitment of several mRNP components to chromatin and incorporation of further mRNP components into nuclear mRNPs, establishing a function of Npl3 in nuclear mRNP assembly. Taken together, we determined the specific function of the RNA-binding activity of the nuclear mRNP component Npl3, an approach that can be applied to many RBPs in any RNA metabolic process.
Previous studies towards reduced oxygen availability have mostly focused on changes in total mRNA expression, neglecting underlying transcriptional and post-transcriptional events. Therefore, we generated a comprehensive overview of hypoxia-induced changes in total mRNA expression, global de novo transcription, and mRNA stability in monocytic THP-1 cells. Since hypoxic episodes often persist for prolonged periods, we further compared the adaptation to acute and chronic hypoxia. While total mRNA changes correlated well with enhanced transcription during short-term hypoxia, mRNA destabilization gained importance under chronic conditions. Reduced mRNA stability not only added to a compensatory attenuation of immune responses, but also, most notably, to the reduction in nuclear-encoded mRNAs associated with various mitochondrial functions. These changes may prevent the futile production of new mitochondria under conditions where mitochondria cannot exert their full metabolic function and are indeed actively removed by mitophagy. The post-transcriptional mode of regulation might further allow for the rapid recovery of mitochondrial capacities upon reoxygenation. Our results provide a comprehensive resource of functional mRNA expression dynamics and underlying transcriptional and post-transcriptional regulatory principles during the adaptation to hypoxia. Furthermore, we uncover that RNA stability regulation controls mitochondrial functions in the context of hypoxia.
Upon antibiotic stress Gram-negative pathogens deploy resistance-nodulation-cell division-type tripartite efflux pumps. These include a H+/drug antiporter module that recognizes structurally diverse substances, including antibiotics. Here, we show the 3.5 Å structure of subunit AdeB from the Acinetobacter baumannii AdeABC efflux pump solved by single-particle cryo-electron microscopy. The AdeB trimer adopts mainly a resting state with all protomers in a conformation devoid of transport channels or antibiotic binding sites. However, 10% of the protomers adopt a state where three transport channels lead to the closed substrate (deep) binding pocket. A comparison between drug binding of AdeB and Escherichia coli AcrB is made via activity analysis of 20 AdeB variants, selected on basis of side chain interactions with antibiotics observed in the AcrB periplasmic domain X-ray co-structures with fusidic acid (2.3 Å), doxycycline (2.1 Å) and levofloxacin (2.7 Å). AdeABC, compared to AcrAB-TolC, confers higher resistance to E. coli towards polyaromatic compounds and lower resistance towards antibiotic compounds.
Lipid acquisition and transport are fundamental processes in all organisms, but many of the key players remain unidentified. Here, we elucidate the lipid-cycling mechanism of the Mycoplasma pneumoniae membrane protein P116. We show that P116 not only extracts lipids from its environment but also self-sufficiently deposits them into both bacterial and eukaryotic cell membranes as well as liposomes. Our structures and molecular dynamics simulation show that the N-terminal region of P116, which resembles an SMP domain, is responsible for perturbing the membrane, while a hydrophobic pocket exploits the chemical gradient to collect the lipids and the protein’s dorsal side acts as a mediator of membrane directionality. Furthermore, ligand binding and growth curve assays suggest the potential for designing small molecule inhibitors targeting this essential and immunodominant protein. We show that P116 is a versatile lipid acquisition and delivery machinery that shortcuts the multi-protein pathways used by more complex organisms. Thus, our work advances the understanding of common lipid transport strategies, which may aid research into the mechanisms of more complex lipid-handling machineries.